PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 

GTCbio

Press Releases

Click on the press release below to view it in its entirety

Receive press releases from GTCbio: By Email RSS Feeds:
Dr. Kenneth Emancipator will discuss, “Programmed Cell Death 1 Ligand” (PD-L1) as a Companion Diagnostic for Pembrolizumab” at Biomarker Summit. - January 06, 2017
Sherie Morrison, Distinguished Professor at UCLA David Geffen School of Medicine, will present, “Antibody Fusions with Interferon for the Treatment of Malignancy” at GTCbio’s ImmunoTx Summit. - November 30, 2016
John Lambert, Executive Vice President at ImmunoGen, to present at 2nd Antibody Drug Conjugates Conference. - November 18, 2016
Stefan Gluck, Vice President, Global Medical Affairs at Celgene, to speak at GTCbio’s 2nd Cancer Diagnostics Conference (Nov 7-8, 2016 in San Francisco, CA). - September 09, 2016
Prof. Terry Hébert at McGill University, to talk on, "Assessing Bias and Allostery in GPCRs using Conformational Biosensors" at GPCR Meeting. - August 27, 2016
Eli Gilboa, Professor of Microbiology & Immunology, University of Miami, to present at 7th Non-Coding RNA & RNAi Therapeutics Conference. - July 28, 2016
Kevin Morris, City of Hope, to discuss “Genomic Dark Matter; The Complexities of Non-Coding RNA from Mechanism to Therapeutics” at Non-Coding RNA & RNAi Conference. - July 27, 2016
Marcus Carr, Vice President at Pfizer, will give a keynote presentation on, “Clinical Development of Gene Therapy for Hemophilia B” at 3rd Cell & Gene Therapy. - July 21, 2016
Michael Egan, Executive Director, Clinical Neuroscience at Merck to present at CNS Diseases World Summit 2016. - July 21, 2016
Hua Xu, Worldwide Medicinal Chemistry at Pfizer, to discuss “Chemical Biology Tools for Target Identification” at 11th Drug Design & Medicinal Chemistry Mtg. - July 19, 2016
TJ Cradick, Head of Genome Editing at CRISPR Therapeutics, to talk on, “Therapeutic Gene Editing with CRISPR/CAS9” at 3rd Cell & Gene Therapy Mtg - July 14, 2016
Erin Keaney, Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a presentation at 11th Drug Design & Medicinal Chemistry. - July 12, 2016
Richard E. Buller, VP at Pfizer, will give a keynote presentation at GTCbio’s Biomarker Summit Europe 2016. - July 10, 2016
Dr. Stephen Chang, Vice President of R&D at NYSCF will give a presentation at GTCbio’s CNS Diseases World Summit 2016. - July 06, 2016
Harry M. Tracy, President of NI Research will lead “An Update on Neurodegeneration...” panel at CNS Diseases World Summit 2016. - July 04, 2016
Michael Naso, Janssen R&D will discuss, “The Future of Biotherapeutics” at GTCbio’s 3rd Cell & Gene Therapy - June 30, 2016
Judy Lieberman, Professor of Pediatrics at Harvard Medical School, will give a keynote presentation at GTCbio’s 7th Non-Coding RNA & RNAi Therapeutics Conference. - June 29, 2016
Diana Colleluori at Bluebird Bio will discuss, “Quality Control Considerations for Commercialization of Autologous Cell Products” at 3rd Cell & Gene Therapy. - June 26, 2016
Mark Trusheim, MIT to present, “Implementing Precision Medicine, Determining Economic Value under Adaptive Biomedical Innovation Pathways“ at the Inaugural Precision Medicine Conference. - June 13, 2016
Susan Hager at Foundation Medicine will give a presentation on, “Precision Medicine in the Information Age” at GTCbio’s Precision Medicine Conference - June 08, 2016
Robert Weinberg, MIT, will give a presentation, on “Mechanisms of Malignant Progression of Carcinomas” at 2nd Cancer Markers & Liquid Biopsies Conference. - June 01, 2016
Paraskevi Giannakakou, Professor of Pharmacology in Medicine & Principal Investigator at Weill-Cornell Medical College, will give a presentation on, “Drug-Target Engagement in CTCs: From Mechanism to Clinical Application in Prostate Cancer” at GTCbio’s 2nd Cancer Markers & Liquid... - May 30, 2016
Johan Skog, CSO at Exosomes Diagnostics, will give a presentation on the current progress in exosome applications at GTCbio’s 2nd Cancer Markers & Liquid Biopsies Conference to be held on July 6-7, 2016 in Boston, MA. Dr. Skog is the Chief Scientific Officer and founding scientist of Exosome... - May 07, 2016
Rebecca Leary from Novartis, will give a presentation on, “Characterizing the Cancer Genome from the Circulation” at GTCbio’s 2nd Cancer Markers & Liquid Biopsies Conference. - April 29, 2016
Helmy Eltoukhy, Guardant to give Keynote on, “From Wired to Wireless: The Guardant Experience with 20,000+ Clinical Liquid Biopsies” at Cancer Markers Conf. - April 27, 2016
Aaron Black, Director of Informatics at Inova Health Systems will present at GTCbio’s Big Data Bioinformatics Conference to be held on May 25-26, 2016 in Boston, MA. Aaron Black is a thought leader in personalized medicine informatics and a results-driven technical leader with a 15+ year record... - April 23, 2016
Harvard’s Michael Seaman talk is entitled “Choosing Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Infection.” - April 22, 2016
Jeffery Schloss, Ph.D., NHGRI to discuss “Developing Technologies for the $1,000 Genome–the Path to Today & Beyond” at GTCbio’s 6th Next Generation Sequencing - April 16, 2016
Howard Federoff, UC Irvine, to speak at the GTCbio’s 3rd Metabolomics - Advances & Applications in Human Disease Conference - April 03, 2016
John Doench, Associate Director, Genetic Perturbation Platform, Broad Institute of MIT and Harvard, to speak at GTCbio’s CRISPR & Genome Engineering Conference. Since joining the Broad Institute in 2009, John Doench has engaged in dozens of collaborations centered on functional genomics. As... - April 03, 2016
Mark Albrecht, BARDA, to Present “Expanding Public–Private Partnerships to Strengthen the Antimicrobial Pipeline” at Anti-Infectives Partnering & Deal-Making - April 02, 2016
George Church at Harvard Medical School will discuss, “New Technologies for Collecting and Interpreting Petabytes for BRAIN and Precision Medicine projects” at GTCbio’s Big Data Bioinformatics conference. - March 30, 2016
Roderick Hubbard at Vernalis will discuss, “Strategies and Outcomes for Fragments for Kinases” at GTCbio’s Med Chem Conference. - March 17, 2016
Roderick Hubbard at Vernalis will discuss, “Strategies and Outcomes for Fragments for Kinases” at GTCbio’s Kinase Inhibitors Design & Screening Conference - March 17, 2016
Sheng Lin‐Gibson, at the National Institute of Standards and Technology of the Federal Agency, will give a presentation at GTCbio’s Stem Cell Summit 2016. - March 17, 2016
Alex Sherman at Massachusetts General Hospital will discuss, “Big Data in Rare Diseases” at GTCbio’s Big Data Bioinformatics conference. - March 10, 2016
Jared Cumming from Merck will discuss, “Discovery of Verubecestat (MK-8931): A beta-Secretase Inhibitor in Phase 3 Clinical Development for Alzheimer’s Disease.” - February 19, 2016
Alan Wright, CMO of Roche Diagnostics, will give a keynote presentation on, “Creating Personalized Diagnostics Ecosystems” at Biomarkers Summit 2016. - February 18, 2016
Je H. Lee, Assistant Professor at Cold Springs Harbor Laboratory will discuss, “Spatial Transcriptomics and Beyond” at GTCbio’s 6th Next Generation Sequencing to be held on May 25-26, 2016 in Boston, MA. The Lee lab at CSHL is advancing in situ technologies, originally developed in... - February 18, 2016
Jared Cumming from Merck will discuss, “Discovery of Verubecestat (MK-8931): A beta-Secretase Inhibitor in Phase 3 Clinical Development for Alzheimer’s Disease.” - February 11, 2016
Tomi Sawyer, Distinguished Scientist & Head of Peptide Drug Discovery & Innovative Technologies at Merck will keynote present at 2nd Protein-Protein Interaction Conference to be held on October 23-24, 2014 in Boston, MA by GTC. GTCbio's upcoming 2nd Protein-Protein Interaction Conference to... - August 14, 2014
Juhi Juneja, Senior Research Investigator at Bristol-Myers Squibb to Speak at 2nd Protein-Protein Interaction Conference, October 23-24, 2014 in Boston, MA. - July 22, 2014
Mark Bunnage, Vice President, Head of Chemistry Biotherapeutics Research at Pfizer to Give a Keynote Presentation at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA) - July 13, 2014
Jianxin Zhang, Deputy Director of Protein Characterization at Sanofi Pasteur to Speak at 2nd Protein-Protein Interaction Conference, October 23-24, 2014 in Boston, MA. - July 06, 2014
Igor Kaltashov, Professor and Graduate Program Director of Chemistry at the University of Massachusetts-Amherst to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA. - July 05, 2014
Nic Angell, Principal Scientist, Process Development at Amgen to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA. - July 05, 2014
Nathanael Gray, Professor, Biological Chemistry and Molecular Pharmacology, Dana Farber Cancer Institute, Harvard Medical School to Give a Featured Presentation at the 3rd Protein Kinases & Drug Design Conference (Oct 23-24, 2014 in Boston, MA). - July 05, 2014
Robert Murphy, Carnegie Mellon University, to Give Keynote Address at Cell Based Assay & Screening Technologies Conference, October 7-8, 2014 in Dublin, Ireland. - June 22, 2014
Panel discussion on “What Sells Big Pharma in CNS Diseases?” to be held at the CNS Diseases World Summit, Sept. 18-19, 2014 in San Francisco, CA - June 19, 2014
Kathleen Coelingh, Senior Director, Medical Affairs at MedImmune to Give a Presentation on, “Development of Pandemic Live Attenuated Influenza Vaccines” at the 3rd Annual Influenza Research and Development Conference on July 9-11, 2014, in Boston, MA, by GTCbio. Dr. Coelingh will discuss... - June 19, 2014
Press Releases 1 - 50 of 242 Page: 1 | 2 | 3 | 4 | 5 | Next
Promote Your Business